Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Efficacy and Safety of Ularitide for the Treatment of Acute Decompensated Heart Failure

ClinicalTrials.gov ID: NCT01661634

Public ClinicalTrials.gov record NCT01661634. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 9:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Ularitide (Urodilatin) Intravenous Infusion in Patients Suffering From Acute Decompensated Heart Failure [TRUE-AHF]

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy and safety of a continuous intravenous (IV) ularitide infusion on the clinical status and outcome of patients with acute decompensated heart failure (ADHF).

Study identification

NCT ID
NCT01661634
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cardiorentis
Industry
Enrollment
2,157 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2012 (Type not available)
Primary completion
Nov 2015 (Actual)
Completion
Mar 2016 (Actual)
Last update posted
Oct 23, 2018

2012 – 2016

United States locations

U.S. sites
39
U.S. states
23
U.S. cities
37
Facility City State ZIP Site status
Not listed Huntsville Alabama 35801 —
Not listed Montgomery Alabama 36106 —
Not listed Sacramento California 95817 —
Not listed Littleton Colorado 80120 —
Not listed Trumbull Connecticut 06611 —
Not listed Washington D.C. District of Columbia 20422 —
Not listed Jacksonville Florida 32216 —
Not listed Lawrenceville Georgia 30046 —
Not listed Peoria Illinois 61606 —
Not listed Rockford Illinois 61107 —
Not listed Kansas City Kansas 66160 —
Not listed Alexandria Louisiana 71303 —
Not listed Worcester Massachusetts 01655 —
Not listed Detroit Michigan 48201 —
Not listed Detroit Michigan 48202 —
Not listed Detroit Michigan 48235 —
Not listed Royal Oak Michigan 48073 —
Not listed Minneapolis Minnesota 55415 —
Not listed St Louis Missouri 63110 —
Not listed Lincoln Nebraska 68526 —
Not listed Newark New Jersey 07107 —
Not listed Brooklyn New York 11203 —
Not listed The Bronx New York 10467 —
Not listed Cincinnati Ohio 45219 —
Not listed Columbus Ohio 43210 —
Not listed Middletown Ohio 45005 —
Not listed Toledo Ohio 43614 —
Not listed Philadelphia Pennsylvania 19141 —
Not listed Charleston South Carolina 29425 —
Not listed Chattanooga Tennessee 37403 —
Not listed Nashville Tennessee 37232 —
Not listed Austin Texas 78758 —
Not listed Dallas Texas 75390 —
Not listed Fort Worth Texas 76104 —
Not listed Houston Texas 77030 —
Not listed Charlottesville Virginia 22908 —
Not listed Midlothian Virginia 23114 —
Not listed Norfolk Virginia 23507 —
Not listed Salem Virginia 24153 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 124 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01661634, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 23, 2018 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01661634 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →